ANTICOGER: Evaluation of Perioperative Management of Curative Anticoagulants in the Geriatric Perioperative Unit in Patient Hospitalized for Femoral Neck Fracture.

Sponsor

Centre Hospitalier Universitaire de Nīmes (Other)

Overall Status

Completed

CT.gov ID

NCT05286671

Collaborator

(none)

Enrollment

Location

1.2

Actual Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Pilot study to evaluate the management of curative anticoagulant prescriptions pre- and postoperatively in elderly patients hospitalized for femoral neck fracture.

Condition or Disease	Intervention/Treatment	Phase
Anticoagulants; Circulating, Hemorrhagic Disorder Femoral Neck Fractures

Study Design

Study Type:

Observational

Actual Enrollment :

30 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Evaluation of Perioperative Management of Curative Anticoagulants in the Geriatric Perioperative Unit in Patient Hospitalized for Femoral Neck Fracture.

Actual Study Start Date :

Feb 1, 2022

Actual Primary Completion Date :

Mar 11, 2022

Actual Study Completion Date :

Mar 11, 2022

Outcome Measures

Primary Outcome Measures

Rate of compliance with the recommendations for direct oral anticoagulants (DOAC).. [Day 0]
Rate of compliance with the french working group on perioperative haemostasis (GIHP) recommendations for DOACrecommendations for DOA.
Rate of compliance with the recommendations for vitamin K antagonists (VKA). [Day 0]
Rate of compliance with the french health authority (HAS) recommendations for VKA

Secondary Outcome Measures

Number of pharmaceutical interventions [Day 0]
Number of pharmaceutical interventions regarding anticoagulant prescriptions
description of pharmaceutical interventions [Day 0]
description of pharmaceutical interventions
Evaluation of the morbi-mortality [Day 0]
Mortality, re-hospitalizations at 30 days, characterization of bleeding complications, characterization of thrombotic complications
Description of the evolution of the plasma dosage of DOAC and the international normalized ratio (INR) and analysis of the operative delay [Day 0]
Value of preoperative DOAC plasma dosage, value of INR dosage pre- and post-op, analysis of the operative delay
description of the population [Day 0]
age, weight, height, body mass index, comorbidities

Eligibility Criteria

Criteria

Ages Eligible for Study:

75 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patient 75 years or older
Hospitalized in the geriatric perioperative unit for a femoral neck fracture between 18/11/2019 and 30/06/2021
Treated with a curative anticoagulant at entry
Patient enrolled in or receiving a social security plan